Personal profile
Research interests
Personal profile
Teaching
External positions
Pontificia Universidad Católica de Chile
2014 → 2018
Pontificia Universidad Católica de Chile
2011 → 2014
Pontificia Universidad Católica de Chile
2009 → 2011
Pontificia Universidad Católica de Chile
2007 → 2009
Cargo USS
- Docente Investigador (a)
Jerarquía Académica
- Profesor Asociado
Línea de Investigación
- Línea de Investigación
Macrodisciplinas
- Macrodisciplinas
Disciplinas ANID
- Disciplinas
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
FONDEF-ID25I10016: NOVEDOSA APROXIMACIÓN PARA EL TRATAMIENTO CONTRA LA FIBROSIS: DESARROLLO Y EVALUACIÓN DE NUEVOS PÉPTIDOS INHIBIDORES DEL FACTOR DE CRECIMIENTO PRO-FIBRÓTICO DE TEJIDO CONECTIVO (CTGF)
Brandan Siques, E. H. (Director(a)), Araya Secchi, R. R. (Deputy director), Lagos Arevalo, C. F. (Investigador(a)), Martínez Fuenzalida, Á. (Investigador(a)) & Faúndez Contreras, J. V. (Investigador(a))
02/07/25 → 01/07/27
Project: PROYECTO DE INVESTIGACIÓN APLICADA
-
FONDECYT R-1241969: Targeting the Mineralocorticoid Receptor Activation as a Novel Approach for Obesity and Metabolic Syndrome
Lagos Arevalo, C. F. (Investigador(a) Responsable), Amoroso, A. J. (CoI), Vecchiola, A. (CoI) & Recabarren-Gajardo, G. (CoI)
Agencia Nacional de Investigaci?n y Desarrollo
01/04/24 → 31/03/28
Project: PROYECTO DE INVESTIGACIÓN
-
FONDECYT R-1241192: Discovery of Novel Multi Targeted Serotonergic Ligands: An Interdisciplinary Approach towards Candidates directed to Social and Cognitive Symptomathic Domains of Neurodevelopmental Diseases
Lagos Arevalo, C. F. (CoI), Recabarren-Gajardo, G. (Investigador(a) Responsable), Egaña, J. T. (CoI) & Sfeir, A. D. C. (CoI)
Agencia Nacional de Investigaci?n y Desarrollo
01/04/24 → 31/03/28
Project: PROYECTO DE INVESTIGACIÓN
-
FONDEQUIP-EQM200058: Mejora del Sistema de Almacenamiento del NLHPC
Lagos Arevalo, C. F. (CoI), San Martín Arístegui, J. R. (CoI), Gallardo Klenner, L. L. (CoI), Maass Sepúlveda, A. E. (CoI), Guerrero Hernandez, G. D. (Investigador(a) Responsable) & Ortega, J. (CoI)
Agencia Nacional de Investigaci?n y Desarrollo
01/01/21 → 30/06/24
Project: PROYECTO DE EQUIPAMIENTO
-
FONDECYT R-1160695: Aldosterone dysregulation in metabolic syndrome, obesity and inflammation: Clinical and in vitro studies
Lagos Arevalo, C. F. (CoI) & Fardella, C. E. (Investigador(a) Responsable)
Agencia Nacional de Investigaci?n y Desarrollo
02/05/18 → 01/04/20
Project: PROYECTO DE INVESTIGACIÓN
-
Nanostructured Lipid Carriers as Physicochemical Modulators of Complex Natural Extracts: Release Behavior and Bile-Induced Remodeling in Biorelevant Media: Release Behavior and Bile-Induced Remodeling in Biorelevant Media
Carrasco-Rojas, J., Lagos, C. F., Simirgiotis, M. J., Arriagada, F., Ortiz, A. C., Solas Soto, J. I. & Veas Albornoz, R. E., 2026, In: Molecules. 31, 6, 1028.Research output: Contribution to journal › Article › peer-review
Open Access -
Nanostructured Lipid Carriers Enhance Ciprofloxacin Antibacterial Activity Through Diffusion-Controlled Release and Modulation of Bacterial Growth Kinetics
Carrasco-Rojas, J., Sandoval, F. I., Solas-Soto, J., Schuh, C. M. A. P., Rubio-Quiroz, L., Lagos, C. F., Arriagada, F. & Ortiz, A. C., 2026, In: Pharmaceutics. 18, 4, 496.Research output: Contribution to journal › Article › peer-review
Open Access -
A complex multisystem disorder including hypopituitarism and hypoparathyroidism, associated with mutation in the gene encoding fatty acid synthase (FASN)
Gregory, L. C., Krywawych, S., Rahman, S., Lagos, C. F., Eaton, S. & Dattani, M. T., 2025, In: Metabolism. 168, 156256.Research output: Contribution to journal › Article › peer-review
Open Access -
HERPUD1 mediates palmitic acid-induced UPR sustaining TNBC aggressiveness and is destabilized by CK2 pharmacological inhibition
Cavieres, V. A., Cortés, O., Arias-Muñoz, E., Álvarez-Indo, J., Aguilera-Olguín, M., Hernández, R., Silva-Pavez, E., Tapia, J. C., Cancino, J., Lagos, C. F., Pástor, T. P., Galarza, A. J., Mardones, G. A., Varas-Godoy, M., Villarreal-Cruz, N., Villarroel-Espindola, F., Saffie, I., González, A., Barrera, M. J. & Ehrenfeld, P. & 4 others, , 2025, In: Cell Death and Disease. 16, 1, 793.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Influence of an Antioxidant Nanomaterial on Oral Tablet Formulation Flow Properties and Critical Quality Attributes
Ortiz, A. C., Carrasco-Rojas, J., Peñaloza, S., Simirgiotis, M. J., Rubio-Quiroz, L., Ruiz, D., Lagos, C. F., Morales, J. & Arriagada, F., 2025, In: Antioxidants. 14, 7, 829.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations